176 results
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
24 Jun 24
Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
7:46am
subject to audit and verification procedures that may result in the final data being materially different from the topline or interim data we previously
8-K
EX-99.1
0pwe9kzod0nbov nv0z
10 May 24
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
8:45am
8-K
EX-99.1
5tmhpftk8dyma
22 Mar 24
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
8:52am
8-K
EX-99.1
17c5v39kcvru2crh7g
18 Mar 24
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
4:05pm
424B5
60eppy1 ynn3e1ysezp
30 Jan 24
Prospectus supplement for primary offering
5:10pm
8-K
EX-99.1
qyka05 y6iy2qsv3
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
8-K
EX-10.1
tslt96z6j2676 v39do7
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
8-K
d0wlvc2
5 Jan 24
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
t8s3oe4yv0 883d3c7
18 Dec 23
U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer
7:10am